Rapid effect of mosapride citrate, 5-HT4 receptor agonist, on fasting blood glucose in Type 2 diabetes patients

J Diabetes Complications. Jul-Aug 2009;23(4):255-6. doi: 10.1016/j.jdiacomp.2008.01.001. Epub 2008 Apr 16.
No abstract available

Publication types

  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Administration, Oral
  • Aged
  • Benzamides / administration & dosage
  • Benzamides / therapeutic use*
  • Blood Glucose / metabolism*
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Glycated Hemoglobin A / metabolism
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / blood
  • Morpholines / administration & dosage
  • Morpholines / therapeutic use*
  • Serotonin 5-HT4 Receptor Agonists*
  • Time Factors
  • Treatment Outcome

Substances

  • Benzamides
  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • Morpholines
  • Serotonin 5-HT4 Receptor Agonists
  • mosapride